HeyJaredMental Health Innovation Updates (GIMBHI)
Insights, perspectives, & news on the world mental, behavioral, & brain health innovation
- Indexed issues, last 90 days
- 17
- Latest publication
- Sep 25, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 14, 2026
Latest issues
GIMBHI’s daily mental health update — 9/25/26 (opens the original)
Read excerpt
🤝 Sword to acquire Headspace, bringing AI Care to world’s most trusted mental health brand (Sword Health, GlobeNewswire) — 09/16/26TL;DR: Sword signed a definitive agreement to acquire Headspace, combining its AI Care platform with Headspace’s 100M-user global reach, 20,000+ employer clients, and 15,000-provider care network, closing by early Q4 2026.👨👩👧 <a href="https://www.businesswire.c
GIMBHI’s daily mental health update — 9/18/26 (opens the original)
Read excerpt
🛡️ Gov. Newsom signs nation’s strongest child safety chatbot and social media laws (Office of Governor Gavin Newsom) — 09/10/26TL;DR: California enacted “Adam’s Law” requiring crisis protocols and safety audits for companion chatbots, banned addictive social media features for users under 16, and expanded child privacy protections against AI exploitation.⚖️ <a href="https://www.beckersbehavioralhealth.com/payer/trump-administratio
GIMBHI’s daily mental health update — 9/17/26 (opens the original)
Read excerpt
💊 Quel Health launches as first telehealth company built around GLP-1s for addiction (Quel Health, PRWeb) — 09/08/26TL;DR: Santa Fe-based Quel Health launched in 41 states with Caron Treatment Centers as founding partner, offering telemedicine for off-label GLP-1 use in substance use disorders based on emerging clinical evidence.⚡ <a href="https://insights.citeline.com/medtech-insight/device-area/diagnostics/flow-neuroscience-launches-at-home-fda-approved-brain-stimu
GIMBHI’s daily mental health update — 9/16/26 (opens the original)
Read excerpt
💊 Lilly completes AtaiBeckley acquisition to advance neuroplastogens for treatment-resistant depression (Eli Lilly and Company, PR Newswire) — 09/11/26TL;DR: Lilly closed its acquisition of clinical-stage AtaiBeckley to advance rapid-acting neuroplastogens including lead program BPL-003 for treatment-resistant depression.🇨🇦 <a href="https://betakit.com/onix-raises-5-million-usd-to-create-ai-librar
Healthcare Game Night on Oct 20 (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="572" src="https://substackcdn.com/image/fetch/$s_!UHDS!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1776a5d5-9169-434f-aeac-e9fc8ce2d28e_770x572.png" w
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Mental Health Innovation Updates (GIMBHI)